PKBO — Peak Bio Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.52m
- $9.33m
- $0.37m
Annual balance sheet for Peak Bio, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|
| Period Length: | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Cash and Equivalents | ||||
| Cash and Short Term Investments | 0.35 | 0.205 | 0.655 | 0.382 |
| Prepaid Expenses | ||||
| Total Other Current Assets | ||||
| Total Current Assets | 0.634 | 0.459 | 3.23 | 2.37 |
| Gross Property, Plant And Equipment | ||||
| Accumulated Depreciation | ||||
| Net Property, Plant And Equipment | 0.536 | 0.381 | 4.06 | 0.153 |
| Other Long Term Assets | ||||
| Total Assets | 1.33 | 1.08 | 7.53 | 2.6 |
| Accounts Payable | ||||
| Accrued Expenses | ||||
| Notes Payable / Short Term Debt | ||||
| Current Portion of Long Term Debt / Capital Leases | ||||
| Total Other Current Liabilities | ||||
| Total Current Liabilities | 1.8 | 2.79 | 10.8 | 20.5 |
| Long Term Debt | ||||
| Total Long Term Debt | ||||
| Total Debt | ||||
| Deferred Income Tax | ||||
| Total Other Liabilities | ||||
| Total Liabilities | 1.92 | 3.01 | 15.6 | 20.8 |
| Common Stock | ||||
| Additional Paid In Capital | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| Other Equity | ||||
| Total Equity | -0.593 | -1.94 | -8.09 | -18.2 |
| Total Liabilities & Shareholders' Equity | 1.33 | 1.08 | 7.53 | 2.6 |
| Total Common Shares Outstanding |